pharmaphorum

SEPTEMBER 26, 2022

As the field strives to strike a delicate balance between safety and efficacy, in the context of increased regulatory scrutiny and safety challenges, attending the 4 th Annual Gene Therapy Analytical Development as an analytical scientist has never been so important. Download the full event guide to find out more.

Gene Therapy 52

Gene Therapy Gene Development Bioassay 52

Pharmaceutical Technology

FEBRUARY 15, 2023

The swift development and deployment of messenger-RNA (mRNA) vaccines against the SARS-CoV-2 virus during the COVID-19 crisis has catapulted the pharmaceuticals industry into a new paradigm. Another area where we tend to see problems is in encapsulation efficiency,” says Andrew Kondratowicz, Bioassay Team Lead, Precision NanoSystems.

Bioassay 130

Bioassay Development RNA Drugs 130

Drug Discovery World

APRIL 4, 2024

Join DDW for this free event, ‘ Higher throughput bioanalytical methods accelerate the development and evaluation of advanced biotherapeutics ’, which is supported by Revvity. Successful development of advanced biotherapeutics relies on extensive characterization and tight quality control.

Bioassay 52

Bioassay Antibody Drug Delivery Scientist 52

Drug Discovery World

MARCH 4, 2024

RA: What advantages can better analysis into assays bring to drug developers? By effectively running bioassays and analysing results, drug developers can efficiently optimise lead compounds, predict in vivo efficacy, and gain insights into the mechanism of action.

Drugs 59

Drugs Bioassay Scientist In-Vivo 59

pharmaphorum

JANUARY 21, 2021

The inaugural Gene Therapy Comparability Summit is the only industry dedicated meeting to ensuring your manufacturing processes are effective and comparable at every stage of development, supporting a seamless transition to the larger scales required for commercialization.

Gene Therapy 52

Gene Therapy Gene Bioassay Manufacturing 52

Drug Discovery World

AUGUST 1, 2023

Using multiple bioassays to gain insights on the effects of the CATCH regimen on different types of immune cells, the researchers showed that their strategy not only reactivated the cycle but also removed obstacles at other stages. The researchers named their approach CATCH.

RNA 52

RNA Bioassay Genome Genomics 52

Drug Discovery World

MARCH 8, 2023

Common industry challenges that emerged at the first meeting of the Council include the automation of data analysis, enabling the Lab of the Future, and the development of industry standards to enable collaboration.

Life Science 52

Life Science Bioassay Scientist Research 52

pharmaphorum

AUGUST 5, 2021

The issue, however, is developing an effective way of targeting them. . Understanding the mechanism of PPIs and developing methods to target aberrant ones has been a key strategy in drug development. The flat interface remains the primary challenge facing the development of PPI modulators.

Protein 126

Protein Gene Bioassay DNA 126

Roots Analysis

JANUARY 16, 2023

During our research, we found out that most of the at-home self-testing kits are developed in the form of strips; these strips are primarily used for monitoring diabetes and are approved by various regulatory authorities, such as the USFDA, ISO and IVD. Cell and Gene Therapy Bioassay Services Market, 2021-2030. Facebook – [link].

Bioassay 52

Bioassay Gene Editing Marketing Gene Therapy 52

Drug Discovery World

FEBRUARY 23, 2023

Kristen Hopson , Vice President of Preclinical Discovery and Development at Generate Biomedicines, and Yup Liu , Associate Director, HTS at Generate Biomedicines, reflect on the impact of AI, ML cloud computing, and advances in laboratory automation and high-throughput screening (HTS) on life science research.

Protein 52

Protein Life Science Bioassay Development 52

Drug Discovery World

JANUARY 19, 2023

Cell engineering is bringing life science into a new era of biotherapeutic discovery and development, disease modelling, and synthetic biology research. Furthermore, evidence of monoclonality must be provided for all cell lines producing biotherapeutic molecules if they are to receive approval from industry regulators.

Engineer 52

Engineer Bioassay Life Science Genome 52

Drug Discovery World

AUGUST 12, 2022

By selecting the correct salt form for an assay or as a reagent, scientists can optimise their research projects, says Andrievs Auseklis Auzin, Developer, Molport, Latvia. As an example, one salt analysis algorithm developed by aggregator MolPort proceeds stepwise: a. The research chemical supply market. In a text field only.

Drugs 52

Drugs Bioassay Development Research 52

Drug Discovery World

MAY 4, 2023

The potential of drug targets Over the next 50 years, new targets emerged and drugs were developed against them. Here, new bioassay technologies helped testing, but more definite answers were required. Often drug targets already validated in academic literature are picked up for drug discovery and development efforts.

Medicine 52

Medicine Protein Drugs Bioassay 52

Drug Discovery World

NOVEMBER 9, 2023

The first three include: Sungjin Park, PhD, CEO, Onegene Biotechnology, on: ‘UniStac: Enzyme-mediated conjugation technology for accelerated development of tetraspecific NASH drug’. Gail Calvert, Field Application Scientist, Sartorius UK, on: ‘Leveraging integrated and advanced technologies for successful cell line development’.

Engineer 52

Engineer Antibody Protein In-Vivo 52

Drug Discovery World

NOVEMBER 30, 2023

Lightcast is developing a novel, programmable microfluidic platform that allows precise and highly flexible control of individual microdroplets using software-generated light patterns. “It GSK has developed high-throughput mammalian and E.

Antibody 59

Antibody Protein Engineer In-Vivo 59

Drug Discovery World

MAY 10, 2023

Drug discovery and development is an arduous process that can cost upwards of $2.6 Drug discovery and development New pharmaceutical small molecule drugs require extensive safety testing before the manufacturer can obtain regulatory approval for use in humans. billion and take over 10 years.

Bioassay 52

Bioassay Genotoxicity Drugs In-Vivo 52

The Pharma Data

MAY 13, 2021

Fructose as a key player in the development of fatty liver disease. How does brain insulin resistance develop in Alzheimer’s disease? Effect of Glucocorticoid-Induced Insulin Resistance on Follicle Development and Ovulation. Aspartame bioassay findings portend human cancer hazards. The Journal of Nutrition. 108.098020.

Insulin 52

Insulin Production Hormones Medicine 52

Pharmaceutical Technology

JANUARY 6, 2023

The preparation of a semi-solid dosage form – from formulation and development, to scale-up, commercial manufacturing, and packaging – should ideally take place under one roof in a contiguous, end-to-end workflow to avoid unnecessary equipment and process changes. Optimising development and scale-up. Particle distribution. Grittiness.

Production 130

Production Manufacturing Development Bioequivalency 130